Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Dragonsden50on Jun 25, 2018 7:50pm

120 Views

Post# 28227132

RE:RE:RE:RE:RE:New Timelines

Excuse me as well as patient 4 did not have cancer reoccurence at 180 days. As for the sorry first 3, need I remind you that is was a reduced dose and as per the treated area, it was CANCER FREE!!! Please, I give you a chance to kick me in the nuts on that one. Make your best move amigo. Glory awaits for you!! As to being confused, not really. I was there and you so obviously weren’t. I am sure
1000% as to what I put forward as to the number of patients and number of sites. Don’t question this as you were not there and if you were there in weasel mode, then correct me but that won’t happen.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments